ライフサイエンスコーパス: add-on

1 polyester fabrics, although with 3- 6% lower add-on.

2 s provided by activated methylenes have been added on 3-(2-nitrovinyl)-1H-indole in very good to exce

3 [Correction added on 8 January 2015 after first online publication:

4 orvastatin, 80 mg; add-on ezetimibe therapy; add-on alirocumab therapy, 75 mg (a PCSK9 inhibitor); an

5 s, current topics, and additional images are added on an ongoing basis.

6 Add-on antidepressants appeared more efficacious than co

7 tify all randomized controlled trials of any add-on antidepressants compared with placebo or no-treat

8 More patients taking add-on antidepressants suffered from abdominal pain, con

9 e is moderate evidence to support initial or add-on antihypertensive therapy with an angiotensin-conv

10 in 16 of 85 (19%) patients allocated to the add-on arm versus 9 of 90 (10%) in the monotherapy arm (

11 ayment System bundling, but not the training add-on, associated with substantial increases in home di

12 top 3 quartiles would prevent 9.4 deaths and add, on average, 2.1 days to life expectancy at an incre

13 under study) varies by day, week, and year, adding on average one-third of a day to total LOS.

14 icated biopsy machines or incorporated into "add-on" biopsy devices for existing PET or SPECT cameras

15 Overall utilization rate of add-on codes increased 264% from 1,006 to 3,657 (P <.001

16 Utilization of the two add-on codes increased even more dramatically.

17 The use of a LABA but not an LTRA as an "add-on controller" is associated with increased risk of

18 Add-on CPAP therapy resulted in no significant changes i

19 Add-on CPAP treatment had no significant changes in 24-h

20 Add-on daclizumab treatment reduced the number of new or

21 In simultaneous regimens, all drugs were added on day 0.

22 Even when added on day 5-6 of culture, cholera toxin still rescues

23 ntravenous rituximab 375 mg/m(2) per day was added on days 1, 8, 15, 22, 56, 84, 112, and 140.

24 ne designs (g = 0.32; 95% CI, 0.14-0.51) and add-on designs (g = 0.40; 95% CI, 0.15-0.65).

25 as compared with control interventions) from add-on designs (in which an experimental intervention ad

26 lone designs and 1.01; 95% CI, 0.55-1.87 for add-on designs).

27 onversely, in both populations, the training add-on did not associate with increases in home dialysis

28 structure of GtfA, revealing a beta-meander add-on domain beyond the catalytic domain.

29 bined with binding assays indicate that this add-on domain contributes to forming an active GtfA-GtfB

30 These findings suggest that fusion with an add-on domain might be a universal mechanism for diverse

31 It represents a novel add-on domain, which is distinct from the all-alpha-tetr

32 The benefits of add-on donor milk over formula are not clear.

33 ine (retigabine) was recently approved as an add-on drug for the treatment of partial seizures in adu

34 Spironolactone was the most effective add-on drug for the treatment of resistant hypertension.

35 would therefore be superior to non-diuretic add-on drugs at lowering blood pressure.

36 hemispheric tDCS cannot be explained by mere add-on effects of anodal and concurrent cathodal stimula

37 By 1998, the ratio of these add-on examinations to primary MPI was 0.94 among cardio

38 applied: uptitration to atorvastatin, 80 mg; add-on ezetimibe therapy; add-on alirocumab therapy, 75

39 aphy/mass spectrometry (GC/MS) system, as an add-on for a rapid LC-MS conversion.

40 A post hoc analysis from the Best Add-On Giving Effective Response (BADGER) study tested t

41 amylamine, has been shown to be an effective add-on in patients that do not respond to selective sero

42 The efficacy of BCI-monitored MI practice as add-on intervention to usual rehabilitation care was eva

43 They were preferentially added on L5B neurons with complex apical tufts rather th

44 Peg-IFN add-on led to significantly more decline in hepatitis B

45 adionuclide MPI and two supplementary codes (add-on left ventricular wall motion or left ventricular

46 Given that roflumilast is recommended as an "add-on" medication to patients with severe disease who w

47 We provide evidence of the benefit of add-on memantine in opioid dependent patients undergoing

48 We investigated whether add-on memantine reduced cytokine levels and benefitted

49 Since GLIM is implemented as an add-on module to an existing inverted microscope, we ant

50 e based TIRF system that could be used as an add-on module to any standard fluorescence microscope ev

51 but that the HNK-1 glycan is preferentially added on N-glycans over O-glycans of NCAM, probably beca

52 ith guidelines-based asthma care (n = 89) or add-on omalizumab (n = 259).

53 As an add-on package built in the R software environment, dcGO

54 It is implemented as an add-on package for the freely-available statistical soft

55 LinkageMapView is a free add-on package written in R that produces high resolutio

56 The add-on packages are freely available at http://www.maths

57 This note describes add-on packages for the Mathematica software system whic

58 7% with statins plus ezetimibe, and 14% with add-on PCSK9 inhibitor.

59 We investigated whether adding on pegylated interferon (Peg-IFN) to ETV therapy

60 Dexamethasone could be added on progression during treatment.

61 We describe an optional add-on protocol for ultrapure HSC isolation from normal

62 The add-on provides real-time negative feedback to regulate

63 MR imaging was used primarily as an add-on rather than a substitute for other imaging modali

64 Furthermore, the consensus sequence add-on required relatively little additional CPU time.

65 Add-on rituximab therapy, four infusions over 15 days.

66 which 2220 patients were assigned to receive add-on rosiglitazone (rosiglitazone group), and 2227 to

67 hat ILs adopt a role as a preconcentrator to add on sensitivity with enhanced selectivity coming from

68 Nitrogen doping leads to an add-on shoulder on the edge of the valence band, the loc

69 Add-on studies in which patients are randomized to stand

70 d, placebo-controlled, crossover, randomised add-on study in which 100 patients with asthma and sympt

71 feron beta were randomly assigned to receive add-on subcutaneous daclizumab 2 mg/kg every 2 weeks (in

72 by including their own algorithms under the Add-On tab.

73 We present a digital electronic add-on technique that vastly improves the dynamic range

74 g preformed DSA using bead-based assay as an add-on test to complement-dependent cytotoxicity (CDC) c

75 sus rather than native sequences is a simple add-on that boosts performance surprisingly well.

76 rts and Future Challenges", I have little to add on the subject.

77 Furthermore, antibodies added on the side of the bilayer opposite that to which

78 Potentially useful add-on therapies for AR include oral leukotriene recepto

79 ids might be useful in guiding the choice of add-on therapies in each child as a step toward achievin

80 laying cards, bingo, Jenga, or ball game) as add-on therapies to conventional rehabilitation over a 2

81 On the basis of less evidence, results for add-on therapies to metformin were similar to those for

82 with H1-antihistamines along with 1 or more add-on therapies.

83 It can be safely considered as add on therapy in patients taking statins (or as monothe

84 s, allopurinol is proving to be an effective add on therapy with good resultant disease control and l

85 itor ezetimibe may offer a viable option for add on therapy; however, questions have been raised rega

86 randomized in a 1:1 ratio to either Peg-IFN add-on therapy (180 microg/week) from week 24 to 48 (n =

87 n electroconvulsive therapy (ECT-arm), or no add-on therapy (MED-arm).

88 The VIDA (Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in

89 re assessed in the AsthmaNet VIDA (Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness) t

90 eroids who are treated with omalizumab as an add-on therapy experience only modest benefits in sympto

91 ne dependence received citicoline or placebo add-on therapy for 12 weeks.

92 acy and safety of subcutaneous omalizumab as add-on therapy for 24 weeks in patients with chronic idi

93 s promising for counteracting fibrosis as an add-on therapy for CD.

94 Omalizumab is approved as add-on therapy for CSU patients; however, its effect on

95 s the efficacy and safety of benralizumab as add-on therapy for patients with severe, uncontrolled as

96 egative, and cognitive symptoms when used as add-on therapy for the treatment of schizophrenia.

97 and 13% fluticasone/montelukast in the Best ADd-on Therapy Giving Effective Responses trial; P = .01

98 placebo, tiotropium 5 mug, but not 2.5 mug, add-on therapy improved the primary end point, peak FEV1

99 nt reduces airway hyper-responsiveness as an add-on therapy in adult asthmatics on inhaled corticoste

100 ntinuous theta burst stimulation is a viable add-on therapy in neglect rehabilitation that facilitate

101 c protocols recommended empirical gentamicin add-on therapy in only 1 of the units.

102 Theophylline is now usually used as an add-on therapy in patients with asthma not well controll

103 Off-label rituximab as an add-on therapy in patients with breakthrough disease on

104 sess the efficacy and safety of dupilumab as add-on therapy in patients with uncontrolled persistent

105 alpha-Blockers are no longer recommended as add-on therapy in some hypertension guidelines.

106 s, they may have the potential to be used as add-on therapy in the treatment of schizophrenia, a dise

107 ndpoint was not reached, 24 weeks of Peg-IFN add-on therapy led to a higher proportion of HBeAg respo

108 Hence, Peg-IFN add-on therapy may facilitate the discontinuation of nuc

109 ion (enalapril 20 mg/day) were randomized to add-on therapy of spironolactone 25 mg, hydrochlorothiaz

110 randomly assigned to either nightly CPAP as add-on therapy or no CPAP.

111 Add-on therapy resulted in more viral decline and appear

112 an incremental benefit, lowering LDL-C as an add-on therapy to a low-dose statin.

113 f depigmented polymerized mite extract as an add-on therapy to basic (ie, topical and, as necessary,

114 neous CYT003 (0.3, 1, or 2 mg) or placebo as add-on therapy to conventional controller medication.

115 airment, non-immersive virtual reality as an add-on therapy to conventional rehabilitation was not su

116 and safety of once-daily tiotropium Respimat add-on therapy to high-dose ICS with 1 or more controlle

117 oved lung function and was well tolerated as add-on therapy to ICS with other maintenance therapies i

118 ffect of salmeterol versus montelukast as an add-on therapy to ICS within 16 weeks of follow-up (the

119 strated that tiotropium is efficacious as an add-on therapy to inhaled corticosteroids (ICSs) with or

120 ptor antagonists either as monotherapy or as add-on therapy to inhaled corticosteroids increased FEV1

121 In 4 trials of LTRAs as add-on therapy to inhaled corticosteroids, the summary R

122 As an add-on therapy to inhaled corticosteroids, they are also

123 s with bouts of OHE, intravenous LOLA (as an add-on therapy to lactulose and ceftriaxone) significant

124 with controls (placebo/ezetimibe), mainly as add-on therapy to maximally tolerated statin.

125 .33 to 0.56]) compared with sulfonylureas as add-on therapy to metformin but had no effect on risks f

126 ravenously daily for 3 days or placebo as an add-on therapy to methylprednisolone.

127 other week, or placebo every other week, as add-on therapy to MTX.

128 fety and efficacy of inhaled treprostinil as add-on therapy to oral bosentan in patients with pulmona

129 Sofosbuvir may be considered as an add-on therapy to ribavirin for the treatment of chronic

130 CAR may be particularly useful as an add-on therapy to selectively enhance the pulmonary vasc

131 treatment of severe exacerbations of COPD as add-on therapy to standard drugs.

132 nterleukin-5 monoclonal antibody approved as add-on therapy to standard of care for patients with sev

133 cribes a randomized, open study of clozapine add-on therapy versus treatment as usual for patients wi

134 dication (MED) and were randomly assigned to add-on therapy with cognitive-behavioral group therapy (

135 herapy and were randomly assigned to receive add-on therapy with either placebo (placebo-minus group,

136 Two of eight patients received add-on therapy with monthly corticosteroid pulses (tempo

137 ognitive-behavioral group therapy (CBT-arm), add-on therapy with ultra-brief pulse continuation elect

138 ophagy-inducing drugs, such as spermidine or add-on therapy with widely used antiatherogenic compound

139 ated to standard blood pressure targets with add-on therapy, excluding other inhibitors of the renin-

140 lone (titrated to 500 mg/day) or placebo, as add-on therapy, for 12 weeks.

141 cently approved for the treatment of hoFH as add-on therapy.

142 of rituximab (375 mg/m(2) intravenously) as add-on therapy.

143 nist require additional treatment options as add-on therapy.

144 000 IU load plus 4,000 IU/d) for 28 weeks as add-on therapy.

145 very 4 weeks) or placebo Q4W for 48 weeks as add on to their standard treatment.

146 e efficacy and safety of dapagliflozin as an add-on to adjustable insulin in patients with inadequate

147 iSPIM is designed as a straightforward add-on to an inverted microscope, permitting conventiona

148 administered through the Respimat device as add-on to background therapy.

149 We present an add-on to BLAST and PSI-BLAST programs to reorder their

150 oids have been evaluated in severe asthma as add-on to conventional therapy.

151 Our method can be used as an add-on to existing methods for estimating heritability a

152 bo group) and when it was administered as an add-on to fibrates (decreases of 60.2+/-12.5% in the 200

153 AMG 853 as an add-on to inhaled corticosteroid therapy demonstrated no

154 As an add-on to losartan, Ly normalized blood pressure and alb

155 Once-daily tiotropium add-on to medium-dose inhaled corticosteroids reduces ai

156 insulin secretion, in monotherapy and as an add-on to metformin.

157 han nesvacumab (an anti-Ang2 antibody) as an add-on to neoadjuvant/adjuvant chemotherapy.

158 Our findings suggest that bumetanide as an add-on to phenobarbital does not improve seizure control

159 feasibility of intravenous bumetanide as an add-on to phenobarbital for treatment of neonatal seizur

160 proved searches and alignments as a standard add-on to PSI-BLAST without any changes of code.

161 It can be easily implemented as an add-on to visual analysis of PSMA PET/CT scans and has t

162 ound to mediate a phase that can be flexibly added on to both ingestive and egestive-rejection progra

163 , in which the study treatment or placebo is added on to known effective treatment, may also be used

164 onal therapies as a substitute for or as an "add on" to conventional medical treatments is uncertain.

165 ground (S(0)) and excited (S(1)) states that add on top of smaller shifts predicted already for these

166 Eleven (13%) of the add-on-treated patients achieved disease remission after

167 esistant were randomly assigned to clozapine add-on treatment (N = 19) or treatment as usual (no cloz

168 results do not suggest benefit of LMTM as an add-on treatment for patients with mild to moderate Alzh

169 e efficacy and safety of empagliflozin as an add-on treatment in patients with type 2 diabetes and CK

170 n(A) blockade is unlikely to be useful as an add-on treatment in such patients.

171 st that vitamin D might have potential as an add-on treatment option in eosinophilic asthma.

172 pport the use of mepolizumab as a favourable add-on treatment option to standard of care in patients

173 ber of drugs have been licensed, more so for add-on treatment than for monotherapy.

174 Timolol monotherapy and timolol add-on treatment to a prostaglandin analog does not lowe

175 h the Respimat device every evening, each as add-on treatment to ICS background therapy, with or with

176 er (or placebo), either as monotherapy or as add-on treatment, for at least 12 weeks.

177 itors of antibiotic resistance mechanisms as add-on treatments for serious drug-resistant infections.

178 re clinical assessment will probably include add-on trials in which a new drug is combined with an in

179 or, the interpretation of placebo controlled add-on trials is straightforward as they have the capaci

180 increase GABAergic function, and may justify add-on trials of the NKCC1 inhibitor bumetanide for the

181 Alternative study designs, such as add-on trials, in which the study treatment or placebo i

182 including placebo-controlled monotherapy or add-on trials, noninferiority studies, and withdrawal tr

183 nsiderations, and the emergence of data from add-on trials, we believe that the future of management

184 The model estimated that adding on triennial SIAs that covered 95% of children ag

185 CIEF has a potential of becoming a practical add-on unit in a wide range of bioanalytical setups, in

186 At week 96, 22 (26%) patients assigned add-on versus 12 (13%) assigned monotherapy achieved HBe

187 NA levels before randomized therapy, Peg-IFN add-on was significantly associated with response (odds